Clearmind Medicine Inc. (CMND)

NASDAQ: CMND · Real-Time Price · USD

0.7800

-0.0487 (-5.88%)

At close: Mar 13, 2026, 4:00 PM EDT

0.7854

+0.0054 (0.69%)

After-hours: Mar 13, 2026, 7:51 PM EDT

Clearmind Medicine Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Cash & Equivalents	9.26	3.92	6.57	5.43	0.13	3.71
Short-Term Investments	1.09	1.66	0.29	0.09	0.19	-
Cash & Short-Term Investments	10.35	5.59	6.86	5.51	0.32	3.71
Cash Growth	74.90%	-18.62%	24.47%	1609.58%	-91.32%	1400.73%
Other Receivables	0.12	0.04	0.05	0.1	0.05	0.13
Total Trade Receivables	0.12	0.04	0.05	0.1	0.05	0.13
Other Current Assets	0.55	0.33	0.18	0.18	0.06	0.13
Total Current Assets	11.02	5.95	7.09	5.79	0.43	3.97
Net Property, Plant & Equipment	0.01	0.02	0.05	0	0.05	0.02
Other Intangible Assets	-	-	-	0.12	0.13	0.16
Other Long-Term Assets	0.02	0.02	0.01	0.04	0.21	0.02
Total Assets	11.14	6.08	7.26	5.95	0.83	4.17
Accounts Payable	0.91	0.68	0.53	0.62	1.4	0.28
Short-Term Debt	-	1.76	-	-	-	-
Current Portion of Leases	0.01	0.02	0.04	-	0.04	-
Other Current Liabilities	1.98	2.43	3.57	4.35	0.5	0.01
Total Current Liabilities	2.91	4.89	4.13	4.97	1.93	0.29
Long-Term Leases	-	-	0.02	-	-	-
Total Long-Term Liabilities	-	-	0.02	-	-	-
Total Liabilities	2.91	4.89	4.15	4.97	1.93	0.29
Common Stock	35.95	26.4	24.17	17.13	6.71	6.38
Additional Paid-in Capital	4.05	2.69	2.98	2.64	2.36	1.08
Accumulated Other Comprehensive Income	-0.02	-0.02	-0.02	-0.02	-0.02	-
Retained Earnings	-31.73	-27.88	-24.02	-18.77	-10.15	-3.58
Shareholders' Equity	8.24	1.19	3.11	0.98	-1.11	3.88
Total Liabilities & Equity	11.14	6.08	7.26	5.95	0.83	4.17
Total Debt	0.01	1.78	0.05	0	0.04	0
Net Cash (Debt)	10.34	3.81	6.81	5.51	0.28	3.71
Net Cash Growth	171.61%	-44.10%	23.51%	1840.56%	-92.35%	1400.73%
Net Cash Per Share	26.54	29.95	87.87	1089.26	262.27	4806.41
Book Value	8.24	1.19	3.11	0.98	-1.11	3.88
Book Value Per Share	21.15	9.38	40.10	194.29	-1020.88	5017.90
Tangible Book Value	8.24	1.19	3.11	0.86	-1.24	3.72
Tangible Book Value Per Share	21.15	9.38	40.10	170.72	-1141.12	4810.95

Updated Jan 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q